Investigating the Evolutionary Impact of Metabolic Flexibility on Physical Activity-Dependent BDNF and Cognition: Insights From the Val66Met Polymorphism

• Status: NOT_YET_RECRUITING
• Trial end date: 2027-05-01

Summary

The goal of this clinical trial is to learn if a state of ketosis and physical activity will increase serum BDNF concentrations and improve cognition, specifically in individuals who possess the Met allele from the BDNF Val66Met SNP. The main questions it aims to answer are:

• Does the combination of ketosis and physical activity increase serum BDNF concentrations and cognition?
• Do Met Carriers of the BDNF Val66Met SNP demonstrate a significantly larger change in serum BDNF after physical activity and a state of ketosis compared to Val/Val Homozygotes?
• Do Met Carriers of the BDNF Val66Met SNP demonstrate a significantly larger increase in cognition after physical activity and a state of ketosis compared to Val/Val Homozygotes?

Researchers will compare a ketosis supplement to a placebo (a look-alike substance that contains no drug) to see if the ketosis supplement and physical activity increases serum BDNF and improves cognition.

Participants will:

• Participate in a drug trial where they will be given the ketosis supplement, and a placebo trial where they will ingest a placebo.
• Participants will donate a whole blood sample and take a cognitive test before and after the ketosis and placebo trial.
• Participants will take a 30-minute treadmill test during both the ketosis and placebo trial, after ingesting either the drug or placebo for each respective trial.

• Phase: PHASE1

Details

• Lead Sponsor: University of Southern California